ABSTRACT

Clinical features: A progressive neurodegenerative disease characterized by hepatosplenomegaly, leading to death by age 2 to 4 years.

Dihyrolipoamide Dehydrogenase Deficiency (DLD Deficiency) Carrier frequency is 1 in 96.